Get the App
S

Cassava Sciences (SAVA)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Cassava Sciences (SAVA)

Cassava Sciences, Inc. is a clinical-stage biotechnology company. The Company is focused on developing the drug for the treatment of neurodegenerative diseases, such as Alzheimers disease. The Company’s products include Simufilam and SavaDx. Its lead... Read more

  • USD24.00
  • USD24.22
  • USD23.48
  • USD51.59
  • -5.00%
  • --
  • 482.56k
  • 805.61k
  • 1.0B
  • 13.84
  • -41.60%

Stock News

: Virgin Orbit stock plunges after report says company will cease operations

1 hour ago

: Virgin Orbit stock plunges after report says company will cease operations

MarketWatch

: Donald Trump reportedly indicted in Stormy Daniels case — first former U.S. president to ever be criminally charged

1 hour ago

: Donald Trump reportedly indicted in Stormy Daniels case — first former U.S. president to ever be criminally charged

MarketWatch

NY grand jury indicts Trump in hush money payment case

1 hour ago

NY grand jury indicts Trump in hush money payment case

CNBC

Earnings Results: Shares of right-wing social platform Rumble rally nearly 30% following Q4 results

1 hour ago

Earnings Results: Shares of right-wing social platform Rumble rally nearly 30% following Q4 results

MarketWatch

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.

Try Premium